Skip to main content
Top
Published in: Rheumatology International 8/2017

01-08-2017 | Genes and disease

Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population

Authors: Yang Xiang, Jing Guo, You-Fan Peng, Hua-Tuo Huang, Yan Lan, Ye-Sheng Wei

Published in: Rheumatology International | Issue 8/2017

Login to get access

Abstract

The aim of this study was to investigate the association of three polymorphisms of CD154 with risk of SLE in Chinese population. The study population comprised 770 Chinese individuals, including 350 SLE patients and 420 healthy controls. The gene polymorphism was measured using Snapshot SNP genotyping assays and confirmed by sequencing. Serum CD154 (sCD154) level was measured by ELISA. Compared with control group, sCD154 levels were significantly increased in case group (P < 0.001). The minor C allele of rs1126535 was associated with a significantly increased risk of SLE as compared to the major T allele (P < 0.001). Furthermore, an increased frequency of C-G-A haplotype was also detected in case group which associated with an increased risk of SLE (P = 0.009). Notably, patients carrying rs1126535CT/CC genotypes had a higher sCD154 level compared with that carrying rs1126535TT genotype (P < 0.05). Unfortunately, analyses on the association between rs1126535 and several clinical manifestations of SLE failed to find any significant results. In conclusion, these results indicated that CD154 gene polymorphisms may associate with the risk of SLE and may play regulation role in the expression of sCD154 in SLE patients.
Literature
1.
go back to reference Aringer M et al (2016) Toward new criteria for systemic lupus erythematosus-a standpoint. Lupus 25(8):805–811CrossRefPubMed Aringer M et al (2016) Toward new criteria for systemic lupus erythematosus-a standpoint. Lupus 25(8):805–811CrossRefPubMed
3.
go back to reference Araujo JA et al (2016) Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus. Rev Bras Reumatol (Rio J) 56(1):28–36CrossRef Araujo JA et al (2016) Th17 cells and CD4(+) multifunctional T cells in patients with systemic lupus erythematosus. Rev Bras Reumatol (Rio J) 56(1):28–36CrossRef
4.
go back to reference Andrade D et al (2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol 67(4):977–987CrossRefPubMedPubMedCentral Andrade D et al (2015) Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol 67(4):977–987CrossRefPubMedPubMedCentral
5.
go back to reference Zhu X et al (2015) Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus. Int J Clin Exp Med 8(10):19223–19231PubMedPubMedCentral Zhu X et al (2015) Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus. Int J Clin Exp Med 8(10):19223–19231PubMedPubMedCentral
6.
go back to reference Abdallah E, Waked E, Abdelwahab MA (2016) Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 35(1):29–34CrossRefPubMed Abdallah E, Waked E, Abdelwahab MA (2016) Evaluating the association of interleukin-10 gene promoter -592 A/C polymorphism with lupus nephritis susceptibility. Kidney Res Clin Pract 35(1):29–34CrossRefPubMed
7.
go back to reference Al-Rayes H et al (2016) Apolipoprotein E Gene polymorphisms in saudi patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 9:81–87PubMedPubMedCentral Al-Rayes H et al (2016) Apolipoprotein E Gene polymorphisms in saudi patients with systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 9:81–87PubMedPubMedCentral
8.
go back to reference Shahin RM et al (2016) Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus in Egyptian Patients. Immunol Invest 45(3):235–242CrossRefPubMed Shahin RM et al (2016) Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus in Egyptian Patients. Immunol Invest 45(3):235–242CrossRefPubMed
10.
go back to reference Oxer DS et al (2011) PPARgamma expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus 20(6):575–587CrossRefPubMed Oxer DS et al (2011) PPARgamma expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. Lupus 20(6):575–587CrossRefPubMed
11.
go back to reference Liu MF et al (2001) Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity 34(2):107–113CrossRefPubMed Liu MF et al (2001) Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity 34(2):107–113CrossRefPubMed
12.
go back to reference Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren’s syndrome. Transl Res 148(6):281–288CrossRefPubMed Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjogren’s syndrome. Transl Res 148(6):281–288CrossRefPubMed
13.
go back to reference Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37(6–7):457–464CrossRefPubMed Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37(6–7):457–464CrossRefPubMed
14.
go back to reference Xu H et al (2015) Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner. Cell Immunol 295(1):46–51CrossRefPubMed Xu H et al (2015) Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner. Cell Immunol 295(1):46–51CrossRefPubMed
15.
go back to reference Willis R et al (2014) Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 32(2):162–167PubMed Willis R et al (2014) Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol 32(2):162–167PubMed
16.
go back to reference Willis R et al (2012) Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21(8):830–835CrossRefPubMed Willis R et al (2012) Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21(8):830–835CrossRefPubMed
17.
go back to reference Goules A et al (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26(3):165–171CrossRefPubMed Goules A et al (2006) Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 26(3):165–171CrossRefPubMed
18.
go back to reference Ciferska H et al (2007) The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol 26(5):723–728CrossRefPubMed Ciferska H et al (2007) The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol 26(5):723–728CrossRefPubMed
19.
go back to reference Urquizu-Padilla M et al (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol 36(5):953–960CrossRefPubMed Urquizu-Padilla M et al (2009) Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol 36(5):953–960CrossRefPubMed
20.
21.
go back to reference Lee SH et al (2014) The Interaction Between Allelic Variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res 6(2):137–141CrossRefPubMed Lee SH et al (2014) The Interaction Between Allelic Variants of CD86 and CD40LG: a common risk factor of allergic asthma and rheumatoid arthritis. Allergy Asthma Immunol Res 6(2):137–141CrossRefPubMed
22.
23.
go back to reference Chadha S et al (2005) Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 13(5):669–676CrossRefPubMed Chadha S et al (2005) Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 13(5):669–676CrossRefPubMed
24.
go back to reference Citores MJ et al (2004) The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis 63(3):310–317CrossRefPubMedPubMedCentral Citores MJ et al (2004) The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Ann Rheum Dis 63(3):310–317CrossRefPubMedPubMedCentral
25.
go back to reference Wang N, Peng XB, Zeng K (2007) Effect of prolactin on CD40/CD154 expression on peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Nan Fang Yi Ke Da Xue Xue Bao 27(9):1382–1384PubMed Wang N, Peng XB, Zeng K (2007) Effect of prolactin on CD40/CD154 expression on peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Nan Fang Yi Ke Da Xue Xue Bao 27(9):1382–1384PubMed
26.
go back to reference Rider V et al (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28(12):2644–2649PubMed Rider V et al (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28(12):2644–2649PubMed
27.
go back to reference Li X et al (2006) Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus 15(12):852–857CrossRefPubMed Li X et al (2006) Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus 15(12):852–857CrossRefPubMed
28.
go back to reference Wang M et al (2009) Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet Disord 10:141CrossRefPubMedPubMedCentral Wang M et al (2009) Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. BMC Musculoskelet Disord 10:141CrossRefPubMedPubMedCentral
29.
go back to reference Wang M, Zhang W, Zhang Y (2009) Activation signal transduction by proline-rich tyrosine kinase 2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Hybridoma (Larchmt) 28(5):333–339CrossRef Wang M, Zhang W, Zhang Y (2009) Activation signal transduction by proline-rich tyrosine kinase 2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Hybridoma (Larchmt) 28(5):333–339CrossRef
30.
go back to reference Peeva E et al (2006) Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice. J Immunol 177(3):1401–1405CrossRefPubMed Peeva E et al (2006) Cutting edge: lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 mice. J Immunol 177(3):1401–1405CrossRefPubMed
Metadata
Title
Association study of CD154 polymorphisms and serum CD154 level with systemic lupus erythematous in Chinese population
Authors
Yang Xiang
Jing Guo
You-Fan Peng
Hua-Tuo Huang
Yan Lan
Ye-Sheng Wei
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3745-y

Other articles of this Issue 8/2017

Rheumatology International 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.